Abstract
On the basis of the numbers ofNocardia strains referred to the National Reference Center for Mycoses and Antifungal Agents (NRC), Institut Pasteur, Paris, in the period from 1987 to 1990, it was estimated that between 150 and 250 cases of nocardiosis are diagnosed in France each year. A total of 63 clinical isolates were referred to the NRC and identified asNocardia asteroides (66.7 %),Nocardia farcinica (23.8 %),Nocardia brasiliensis (3.2 %),Nocardia otitidiscaviarum (4.8 %) andNocardia carnea (1.5 %).Nocardia asteroides accounted for 71.4 % of pulmonary infections, 80.0 % of central nervous system infections and 80.0 % of systemic infections. Patients infected withNocardia farcinica died in 57.1 % of cases, compared with 17.6 % of patients infected withNocardia asteroides. Corticosteroid therapy represented a significant factor in mortality. Isolates ofNocardia asteroides revealed variable resistance, whereas isolates ofNocardia farcinica were resistant to most antimicrobial agents. Only amoxicillin/clavulanic acid, imipenem, cefoxitin, kanamycin, amikacin, minocycline and vancomycin showed activity against both species. Nocardiosis caused byNocardia farcinica may be a growing problem because of the relatively high incidence in AIDS patients and the resistance of this species to most antimicrobial agents.
Similar content being viewed by others
References
Goodfellow M, Lechevalier MP Nocardioforms, genusNocardia Trevisan 1889, 9AL. In: Williams ST, Sharpe ME, Holt JG (ed): Bergey's manual of systematic bacteriology, volume 4. Williams & Wilkins, Baltimore, 1989, p. 2350–2361.
Pulverer G, Schall KP Pathogenicity and medical importance of aerobic and anaerobic actinomycetes. Zentralblatt für Bakteriologie 1978, 6, Supplement: 417–427.
Pulverer G, Schall KP Soil occurrence of pathogenic nocardiae. Zentralblatt für Bakteriologie 1978, 6, Supplement: 429–434.
Schaal KP, Beaman BL Clinical significance of actinomycetes. In: Goodfellow M, Mordarski M, Williams ST (ed): The biology of the actinomycetes. Academic Press, London, 1984, p. 389–424.
Filice GA Nocardiosis. In: Sarosi GA, Davies SF (ed): Fungal diseases of the lung. Grune & Stratton, Orlando, FL, 1986, p. 231–250.
Hay RJ Nocardial infections of the skin. Journal of Hygiene 1983, 91: 385–391.
Smego RA, Gallis HA The clinical spectrum ofNocardia brasiliensis infection in the United States. Reviews of Infectious Diseases 1984, 6: 164–180.
Rippon JW Medical mycology. The pathogenic fungi and the pathogenic actinomycetes. Saunders, Philadelphia, 1988, p. 80–103.
Curry WA Human nocardiosis. A clinical review with selected case reports. Archives of International Medicine 1980, 140: 818–826.
Harris GK Nocardiosis: a literature review and a case report ofNocardia asteroides infection. American Journal of Medical Technology 1980, 46: 44–48.
Kim J, Minamoto GR, Grieco MH Nocardial infection as a complication of AIDS: report of six cases and review. Reviews of Infectious Diseases 1991, 13: 624–629.
Beaman BL, Sugar AM Interaction ofNocardia in naturally acquired infection in animals. Journal of Hygiene 1983, 91: 393–419.
Mishra SK, Gordon RE, Barnett DA Identification of nocardiae and streptomycetes of medical importance. Journal of Clinical Microbiology 1980, 11: 728–736.
Lerner PI Nocardia species. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, Edinburgh, 1990, p. 1926–1932.
Gonzalez-Ochoa A Virulence of nocardiae. Canadian Journal of Microbiology 1973, 19: 901–904.
Murray JF, Finegold SM, Froman, Will DW The changing spectrum of nocardiosis, a review and presentation of nine cases. American Review of Respiratory Diseases 1961, 83: 315–320.
Palmer OL, Harvey RL, Wheeler JK Diagnostic and therapeutic considerations inNocardia asteroides infection. Medicine 1974, 53: 391–401.
Beaman BL, Burnside J, Edwards B, Causey W Nocardial infections in the United States, 1972–1974. Journal of Infectious Diseases 1976, 134: 286–289.
Staneck JL, Roberts GD Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Applied Microbiology 1974, 28: 226–231.
Minnikin DE, Alshamaony L, Goodfellow M Differentiation ofMycobacterium, Nocardia and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. Journal of General Microbiology 1975, 38: 200–204.
Gordon MA Aerobic pathogenicActinomycetaceae. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 249–262.
Boiron P, Provost F Characterization ofNocardia, Rhodococcus andGordona species by in vitro susceptibility testing. Zentralblatt für Bakteriologie 1990, 274: 203–213.
McNeil MM, Brown JM, Jarvis WR, Ajello L Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Reviews of Infectious Diseases 1990, 12: 778–783.
Tsukamura M Numerical analysis of the taxonomy of nocardiae and rhodococci. Microbiology and Immunology 1982, 26: 1101–1119.
Yano I, Imaeda T, Tsukamura M Characterization ofNocardia nova. International Journal of Systematic Bacteriology 1990, 40: 170–174.
Lechevalier MP The taxonomy of the genusNocardia: some light at the end of the tunnel. In: Goodfellow M, Brownell GH, Serrano JA (ed): The biology of the nocardiae. Academic Press, London, 1976, p. 1–38.
Wallace RJ, Tsukamura M, Brown BA, Brown J, Steingrube VA, Zhang Y, Nash DR Cefotaxime-resistantNocardia asteroides strains are isolates of the controversial speciesNocardia farcinica. Journal of Clinical Microbiology 1990, 28: 2726–2732.
Schaal KP Actinomycetes as human pathogens. In: Okami Y, Beppu T, Ogawara H (ed): Biology of actinomycetes, 1988. Japan Scientific Societies Press, Tokyo, 1988, p. 277–282.
Berd D Nocardia brasiliensis infections in the United States: a report of nine cases and a review of the literature. American Journal of Clinical Pathology 1973, 60: 254–258.
Schaal KP, Bickenbach H Soil occurrence of pathogenic nocardiae. Zentralblatt für Bakteriologie 1978, 6, Supplement: 429–434.
Holtz HA, Lavery DP, Kapila R Actinomycetales infection in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1985, 102: 203–205.
Presant CA, Wiernik PH, Serpick AA Factors affecting survival in nocardiosis. American Review of Respiratory Diseases 1973, 108: 1444–1448.
Smego RA, Moeller MB, Gallis HA Trimethoprim-sulfamethoxazole therapy forNocardia infections. Archives of internal Medicine 1983, 143: 711–718.
Schaal KP, Schütt-Gerowitt H, Goldmann A In vitro and in vivo studies on the efficacy of various antimicrobial agents in the treatment of human nocardiosis. In: Szabo G, Biro S, Goodfellow M (ed): Biological, biochemical and biomedical aspects of actinomycetes. Akadémial Kiado, Budapest, 1985, p. 619–633.
Boiron P, Provost F In vitro susceptibility ofNocardia spp. and its taxonomic implication. Journal of Antimicrobial Chemotherapy 1988, 22: 623–630.
Gombert ME Susceptibility ofNocardia asteroides to various antibiotics including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1982, 21: 1011–1012.
Gombert ME, Aulicino TM, duBouchet L, Berkowitz LR Susceptibility ofNocardia asteroides to new quinolones and β-lactams. Antimicrobial Agents and Chemotherapy 1987, 31: 2013–2014.
Berkey P, Moore D, Rolston K In vitro susceptibility ofNocardia species to newer antimicrobial agents. Antimicrobial Agents and Chemotherapy 1988, 32: 1078–1079.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boiron, P., Provost, F., Chevrier, G. et al. Review of nocardial infections in France 1987 to 1990. Eur. J. Clin. Microbiol. Infect. Dis. 11, 709–714 (1992). https://doi.org/10.1007/BF01989975
Issue Date:
DOI: https://doi.org/10.1007/BF01989975